Categories: Longevity & Epigenetic Research Peptides
Reviewed by scientific advisors for accuracy in labeling and documentation.
FOXO4-DRI is a synthetic research peptide supplied by Peak Performance Plus+ exclusively for laboratory and in-vitro research purposes. This compound is referenced in scientific literature involving cellular senescence models, protein–protein interaction studies, and regulated cell signaling pathway research within controlled experimental environments.
This kit includes 10 individual vials, each containing 10mg of lyophilized FOXO4-DRI. Every vial is clearly labeled for compound identification and concentration reference only. No preparation instructions, dosage information, or application guidance are provided with this product.
FOXO4-DRI is not approved for human or animal use and is not marketed as a pharmaceutical product, dietary supplement, or therapeutic agent. It is supplied strictly for non-clinical laboratory research conducted by qualified professionals. Purchasers are responsible for ensuring proper storage, handling procedures, regulatory compliance, and lawful acquisition within their jurisdiction.
Peak Performance Plus+ maintains a structured and transparent catalog system to support organized compound sourcing while prioritizing compliance, responsible distribution standards, and clear research-only positioning.
Research Use Only. Not for human or animal use. Not FDA approved.